<DOC>
	<DOCNO>NCT01667653</DOCNO>
	<brief_summary>This randomize , double-blind , placebo control , single centre ; 21 day phase II clinical trial healthy volunteer . Following baseline visit day randomization , treatment Augmentin 875mg 7 day give . Concurrently antibiotic treatment subject also receive study treatment , either probiotic placebo . Daily Bowel Habit Diary complete subject . The subject ask collect fecal sample microbiological examination . The primary objective study evaluate maintenance intestinal microbiota composition antibiotic treatment Augmentin 875mg . Secondary objective evaluate reduction side effect associate antibiotic use .</brief_summary>
	<brief_title>Probiotic Product Healthy Adults Undergoing Antibiotic Treatment</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Male female age 18 50 year . Healthy determine laboratory result , medical history physical exam Willing give voluntary , write , inform consent participate study Women pregnant , breastfeeding , plan become pregnant course trial Body mass index â‰¥ 30 kg/m2 Average number form bowel movement &gt; 3 per day &lt; 3 per week Smokers Participation clinical research trial within 30 day prior randomization Use antibiotic within 60 day prior randomization . Habitual use pro and/or prebiotic product . Follows vegetarian vegan diet Unstable medical condition Any evidence acute chronic gastrointestinal disorder Alcohol use &gt; 2 standard alcoholic drink per day and/or alcohol drug abuse within past year Allergy sensitivity test product ingredient antibiotic Any condition Investigator 's opinion may adversely affect subject 's ability complete study measure may pose significant risk subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>